{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:24:37Z","timestamp":1740108277060,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011240","name":"Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Foundation","doi-asserted-by":"publisher","award":["T32 NIDDK Grant T32DK007782","F32 NIDDK Grant F32DK126232","by K-12 K12-DK111011-06 UroEPI Career Development Program"],"award-info":[{"award-number":["T32 NIDDK Grant T32DK007782","F32 NIDDK Grant F32DK126232","by K-12 K12-DK111011-06 UroEPI Career Development Program"]}],"id":[{"id":"10.13039\/100011240","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00192-024-05836-x","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T17:19:35Z","timestamp":1719595175000},"page":"1605-1612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Prospective Observational Study of Posterior Tibial Nerve Stimulation in Multiple Sclerosis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6977-5280","authenticated-orcid":false,"given":"Giulia Maria Rosa","family":"Ippolito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-6746","authenticated-orcid":false,"given":"Rita R.","family":"Palanjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Mao-Draayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristides","family":"Capizzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paholo","family":"Barboglio-Romo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Quentin","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Daignault-Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Van Til","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne P.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Stoffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"issue":"1","key":"5836_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis\u2014a review. Eur J Neurol. 2019;26(1):27\u201340. https:\/\/doi.org\/10.1111\/ene.13819.","journal-title":"Eur J Neurol."},{"issue":"10","key":"5836_CR2","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029\u201340. https:\/\/doi.org\/10.1212\/WNL.0000000000007035.","journal-title":"Neurology"},{"issue":"11","key":"5836_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","volume":"17","author":"N Koch-Henriksen","year":"2021","unstructured":"Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021;17(11):676\u201388. https:\/\/doi.org\/10.1038\/s41582-021-00556-y.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5836_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7224\/1537-2073.2013-040","volume":"17","author":"KM Khalaf","year":"2015","unstructured":"Khalaf KM, Coyne KS, Globe DR, Armstrong EP, Malone DC, Burks J. Lower urinary tract symptom prevalence and management among patients with multiple sclerosis. Int J MS Care. 2015;17(1):14\u201325. https:\/\/doi.org\/10.7224\/1537-2073.2013-040.","journal-title":"Int J MS Care"},{"issue":"4","key":"5836_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ucl.2010.06.003","volume":"37","author":"JT Stoffel","year":"2010","unstructured":"Stoffel JT. Contemporary management of the neurogenic bladder for multiple sclerosis patients. Urol Clin North Am. 2010;37(4):547\u201357. https:\/\/doi.org\/10.1016\/j.ucl.2010.06.003.","journal-title":"Urol Clin North Am"},{"key":"5836_CR6","doi-asserted-by":"publisher","DOI":"10.16966\/2379-7150.105","author":"L Cox","year":"2015","unstructured":"Cox L, Cameron AP, Wittman D, Papin JE, Stoffel JT. Analysis of urinary symptoms and urodynamic findings in multiple sclerosis patients by gender and disease subtype. J Neurol Neurobiol. 2015. https:\/\/doi.org\/10.16966\/2379-7150.105.","journal-title":"J Neurol Neurobiol"},{"issue":"5","key":"5836_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrurol.2016.53","volume":"13","author":"V Ph\u00e9","year":"2016","unstructured":"Ph\u00e9 V, Chartier-Kastler E, Panicker JN. Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol. 2016;13(5):275\u201388. https:\/\/doi.org\/10.1038\/nrurol.2016.53.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"5836_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12894-020-00629-y","volume":"20","author":"GI Lane","year":"2020","unstructured":"Lane GI, Mao-Draayer Y, Barboglio-Romo P, et al. A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods. BMC Urol. 2020;20(1):58. https:\/\/doi.org\/10.1186\/s12894-020-00629-y.","journal-title":"BMC Urol"},{"issue":"4","key":"5836_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","volume":"183","author":"KM Peters","year":"2010","unstructured":"Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438\u201343. https:\/\/doi.org\/10.1016\/j.juro.2009.12.036.","journal-title":"J Urol"},{"issue":"11","key":"5836_CR10","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1177\/1352458519894714","volume":"26","author":"MS Rahnama\u2019i","year":"2020","unstructured":"Rahnama\u2019i MS. Neuromodulation for functional bladder disorders in patients with multiple sclerosis. Mult Scler. 2020;26(11):1274\u201380. https:\/\/doi.org\/10.1177\/1352458519894714.","journal-title":"Mult Scler"},{"issue":"8","key":"5836_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1080\/03007995.2021.1920899","volume":"37","author":"N Kachru","year":"2021","unstructured":"Kachru N, Holmes HM, Johnson ML, Chen H, Aparasu RR. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study. Curr Med Res Opin. 2021;37(8):1303\u201313. https:\/\/doi.org\/10.1080\/03007995.2021.1920899.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"5836_CR12","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/nau.24936","volume":"41","author":"EA Enemchukwu","year":"2022","unstructured":"Enemchukwu EA, Subak LL, Markland A. Barriers and facilitators to overactive bladder therapy adherence. Neurourol Urodyn. 2022;41(8):1983\u201392. https:\/\/doi.org\/10.1002\/nau.24936.","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"5836_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11940-017-0470-5","volume":"19","author":"Y Safarpour","year":"2017","unstructured":"Safarpour Y, Mousavi T, Jabbari B. Botulinum toxin treatment in multiple sclerosis\u2014a review. Curr Treat Options Neurol. 2017;19(10):33. https:\/\/doi.org\/10.1007\/s11940-017-0470-5.","journal-title":"Curr Treat Options Neurol"},{"issue":"10","key":"5836_CR14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/1352458520972267","volume":"27","author":"R Sacco","year":"2020","unstructured":"Sacco R, Braga A, Disanto G, Digesu GA, Maino P, Koetsier E, Caccia G, Serati M, Renard J, Gobbi C, Zecca C. Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients. Mult Scler. 2020;27(10):1577\u201384. https:\/\/doi.org\/10.1177\/1352458520972267.","journal-title":"Mult Scler"},{"issue":"7","key":"5836_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/ner.12846","volume":"21","author":"LL Zimmerman","year":"2018","unstructured":"Zimmerman LL, Gupta P, O\u2019Gara F, Langhals NB, Berger MB, Bruns TM. Transcutaneous electrical nerve stimulation to improve female sexual dysfunction symptoms: a pilot study. Neuromodulation. 2018;21(7):707\u201313. https:\/\/doi.org\/10.1111\/ner.12846.","journal-title":"Neuromodulation"},{"issue":"10","key":"5836_CR16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00192-019-04027-3","volume":"30","author":"V Kershaw","year":"2019","unstructured":"Kershaw V, Khunda A, McCormick C, Ballard P. The effect of percutaneous tibial nerve stimulation (PTNS) on sexual function: a systematic review and meta-analysis. Int Urogynecol J. 2019;30(10):1619\u201327. https:\/\/doi.org\/10.1007\/s00192-019-04027-3.","journal-title":"Int Urogynecol J"},{"key":"5836_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/RRU.S124981","volume":"9","author":"LL de Wall","year":"2017","unstructured":"De Wall LL, Heesakkers JP. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Res Rep Urol. 2017;9:145\u201357. https:\/\/doi.org\/10.2147\/RRU.S124981.","journal-title":"Res Rep Urol"},{"key":"5836_CR18","doi-asserted-by":"publisher","first-page":"2700227","DOI":"10.1155\/2022\/2700227","volume":"2022","author":"A Al-Danakh","year":"2022","unstructured":"Al-Danakh A, Safi M, Alradhi M, et al. Posterior tibial nerve stimulation for overactive bladder: mechanism, classification, and management outlines. Parkinsons Dis. 2022;2022:2700227. https:\/\/doi.org\/10.1155\/2022\/2700227.","journal-title":"Parkinsons Dis"},{"issue":"2","key":"5836_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.eururo.2006.02.011","volume":"50","author":"MS Elkelini","year":"2006","unstructured":"Elkelini MS, Hassouna MM. Safety of MRI at 1.5 Tesla in patients with implanted sacral nerve neurostimulator. Eur Urol. 2006;50(2):311\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2006.02.011.","journal-title":"Eur Urol"},{"issue":"6","key":"5836_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.msard.2015.08.009","volume":"4","author":"P Kosa","year":"2015","unstructured":"Kosa P, Komori M, Waters R, et al. Novel composite MRI scale correlates highly with disability in multiple sclerosis patients. Mult Scler Relat Disord. 2015;4(6):526\u201335. https:\/\/doi.org\/10.1016\/j.msard.2015.08.009.","journal-title":"Mult Scler Relat Disord"},{"key":"5836_CR21","doi-asserted-by":"publisher","first-page":"104252","DOI":"10.1016\/j.msard.2022.104252","volume":"68","author":"MH Marzouk","year":"2022","unstructured":"Marzouk MH, Darwish MH, El-Tamawy MS, Morsy S, Abbas RL, Ali AS. Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: a prospective randomized controlled study. Mult Scler Relat Disord. 2022;68:104252. https:\/\/doi.org\/10.1016\/j.msard.2022.104252.","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"5836_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1177\/1352458511414040","volume":"17","author":"C Gobbi","year":"2011","unstructured":"Gobbi C, Digesu GA, Khullar V, El Neil S, Caccia G, Zecca C. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler. 2011;17(12):1514\u20139. https:\/\/doi.org\/10.1177\/1352458511414040.","journal-title":"Mult Scler"},{"issue":"3","key":"5836_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.juro.2013.09.036","volume":"191","author":"C Zecca","year":"2014","unstructured":"Zecca C, Digesu GA, Robshaw P, Singh A, Elneil S, Gobbi C. Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. J Urol. 2014;191(3):697\u2013702. https:\/\/doi.org\/10.1016\/j.juro.2013.09.036.","journal-title":"J Urol"},{"key":"5836_CR24","doi-asserted-by":"publisher","first-page":"103392","DOI":"10.1016\/j.msard.2021.103392","volume":"58","author":"F Guitynavard","year":"2022","unstructured":"Guitynavard F, Mirmosayyeb O, Razavi ERV, et al. Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Mult Scler Relat Disord. 2022;58:103392. https:\/\/doi.org\/10.1016\/j.msard.2021.103392.","journal-title":"Mult Scler Relat Disord"},{"key":"5836_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.urology.2021.02.005","volume":"153","author":"C Du","year":"2021","unstructured":"Du C, Berg W, Siegal AR, et al. Real-world compliance with percutaneous tibial nerve stimulation maintenance therapy in an American population. Urology. 2021;153:119\u201323. https:\/\/doi.org\/10.1016\/j.urology.2021.02.005.","journal-title":"Urology"},{"issue":"10","key":"5836_CR26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00192-011-1507-z","volume":"22","author":"PE Zimmern","year":"2011","unstructured":"Zimmern PE, Dandreo KJ, Sirls L, et al. Lessons from a patient experience survey in a randomized surgical trial of treatment of stress urinary incontinence in women. Int Urogynecol J. 2011;22(10):1273\u20138. https:\/\/doi.org\/10.1007\/s00192-011-1507-z.","journal-title":"Int Urogynecol J"},{"issue":"5A","key":"5836_CR27","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.1111\/bju.14651","volume":"123","author":"J Salatzki","year":"2019","unstructured":"Salatzki J, Liechti MD, Spanudakis E, et al. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder. BJU Int. 2019;123(5A):E20\u20138. https:\/\/doi.org\/10.1111\/bju.14651.","journal-title":"BJU Int"},{"issue":"7","key":"5836_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/ner.12764","volume":"21","author":"S Sanagapalli","year":"2018","unstructured":"Sanagapalli S, Neilan L, Lo JYT, et al. Efficacy of percutaneous posterior tibial nerve stimulation for the management of fecal incontinence in multiple sclerosis: a pilot study. Neuromodulation. 2018;21(7):682\u20137. https:\/\/doi.org\/10.1111\/ner.12764.","journal-title":"Neuromodulation"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-024-05836-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T02:01:57Z","timestamp":1725760917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-024-05836-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5836"],"URL":"https:\/\/doi.org\/10.1007\/s00192-024-05836-x","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"type":"print","value":"0937-3462"},{"type":"electronic","value":"1433-3023"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are 13 authors for this manuscript instead of the maximum 6 required. We require extra authors as the study involves two departments, both urology and neuroradiology, in addition to their respective data analysis teams. Additionally, the urology department at Michigan Medicine required multiple physicians involved with formulating the study idea and design and helping with recruiting participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship Justification"}},{"value":"Institutional Review Board approval was obtained for this study from the University of Michigan: HUM00153287. Participants provided written informed consent prior to participating in the study protocol. All amendments to the IRB were be declared on final publication of study and at the trial registry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics of Approval Statement and Patient Consent Statement"}},{"value":"Y.M.-D. has served as a consultant and\/or received grant support from: Acorda, Bayer Pharmaceutical, Biogen Idec, EMD Serono, Genzyme, Novartis, Questor, Chugai Pharmaceuticals, and Teva Neuroscience. Y.M.-D. is currently supported by grants from the NIH NIAID Auto-immune Center of Excellence: UM1-AI110557; NIH NINDS R01-NS080821, PCORI, Chugai, Novartis, and Genzyme. A.P.C.: reports personal fees from Wellspect, grants from Medtronic, outside of the submitted work. J.S. is supported by grants from the Department of Defense and received grant support from Ipsen and Uroplasty. None of the other authors report any conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}